Plain-English translation of NCT05451004 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new approach to radiation therapy for people with oropharyngeal cancer (cancer of the throat). Instead of treating both sides of the neck with radiation, researchers want to see if they can use special imaging called SPECT-CT to map the lymph nodes and treat only the side of the neck where cancer is likely to spread. The goal is to control the cancer just as well as standard treatment while causing fewer side effects.
Currently, people with one-sided throat cancer receive radiation to both sides of the neck to prevent cancer from spreading. However, treating both sides can cause more side effects and affect quality of life. This trial is testing whether using advanced imaging to target only the affected side works just as well while reducing harm.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two groups: one group will receive standard radiation therapy to both sides of the neck, and the other group will receive radiation guided by SPECT-CT imaging to target one side of the neck. You will receive a small injection of radioactive dye to help map the lymph nodes, followed by radiation therapy. You will complete quality of life surveys at various points during and after treatment, and return for follow-up visits to monitor how well the treatment worked and track any side effects.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
United States